Ultima-Oxa 50 mg 50 Tablets Ultima Pharma USA

Product Overview

Ultima-Oxa 50 mg 50 Tablets Ultima Pharma USA contains oxandrolone, the high-potency anabolic steroid (C19H30O3) recognized under Anavar/Oxandrin pharmaceutical naming conventions. Each tablet provides 50 mg strength—significantly exceeding standard 2.5/10 mg prescription formats—with 50 tablets per sealed unit for structured high-strength cataloging.​

The product belongs to Ultima Pharma USA’s domestic anabolic steroid range, emphasizing U.S. warehousing, encrypted verification, and performance-grade specifications matching Schedule III controlled substance protocols. This elevated dosage configuration serves specialist eCommerce platforms where advanced buyers require precise potency declaration and batch traceability essential for regulated distribution.​

Ultima-Oxa 50 mg addresses knowledgeable adult consumers (21+) familiar with high-dosage anabolic steroids rather than pharmaceutical or general supplement categories, prioritizing commercial positioning without protocols or outcome claims.​

Brand & Manufacturer Information

Ultima Pharma USA specializes in U.S.-domesticated anabolic steroids, SARMs, and growth compounds manufactured to performance specifications with domestic fulfillment eliminating customs exposure. Ultima-Oxa features consistent 50 mg tablet morphology, premium bottle sealing, and catalog positioning alongside institutional-grade anabolics rather than recreational supplements.​

The brand maintains encrypted batch verification and domestic warehousing supporting DEA-compliant resellers managing Schedule III inventories. Multiple oxandrolone strengths enable tiered cataloging while high 50 mg presentation differentiates Ultima from standard 10 mg pharmaceutical equivalents.​

Active Compound Information

Ultima-Oxa contains oxandrolone (17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one), 17α-alkylated DHT derivative exhibiting ~320-630 anabolic rating with minimal aromatization or estrogenic conversion. Molecular weight 306.44; Schedule III controlled substance under Anabolic Steroid Control Act due to high anabolic:androgenic dissociation and hepatotoxicity profile at elevated dosing.​

50 mg strength represents 5-20x standard prescription Oxandrin (2.5-10 mg) while maintaining identical C2-oxa substitution enabling oral bioavailability without 17-keto reduction. WADA S1 prohibited; regulated under 21 CFR 1308.13. Listing identifies specifications without mechanisms or applications.​

Product Specifications

• Product name: Ultima-Oxa 50 mg 50 Tablets Ultima Pharma USA

• Brand/manufacturer: Ultima Pharma USA​

• Active compound: Oxandrolone (C19H30O3)​

• Strength: 50 mg per tablet​

• Quantity per pack: 50 tablets​

• Dosage form: Oral tablets

• Category: Schedule III anabolic steroid​

• Appearance: White oval/scored tablets per high-dosage design

• Primary packaging: Tamper-evident HDPE bottle​

• Label elements: “50 mg”, total count, encrypted batch code​

Quality Control & Testing Standards

High-dosage oxandrolone requires enhanced potency assay (90-110% 50 mg claim), dissolution profiling, and hepatoprotectant stability testing beyond standard 10 mg formulations. Ultima Pharma USA publishes domestic lab certificates verifying C19H30O3 identity, 50 mg uniformity, and Schedule III-compliant excipient profiles.​

50-tablet premium bottling with verification coding prevents diversion common in high-potency conversions; domestic warehousing maintains 24-month stability per accelerated testing.​

Intended Use & Market Positioning

Ultima-Oxa 50 mg 50 Tablets serves institutional performance buyers and CIII-authorized researchers managing high-dosage anabolic inventories. 50 mg strength excludes pharmaceutical crossover, positioning exclusively within advanced domestic catalogs. No protocols represented.​

Packaging, Storage & Handling

Sealed HDPE bottles with desiccant per CIII requirements protect from photo-oxidation; encrypted coding enables post-receipt verification. Controlled room temperature (20-25°C), locked access per DEA protocols; facilities maintain lot-specific inventory logs.​

Purchasing & Availability Information

Domestic U.S. platforms provide CIII-compliant encrypted checkout, 21+ verification, and Priority Mail discreet fulfillment from verified warehouses. “50 mg 50 Tablets” SKU differentiates from 10-25 mg variants; supports institutional repeat procurement without international delays.​

Legal & Regulatory Disclaimer

Oxandrolone constitutes DEA Schedule III controlled substance; non-medical distribution/possession violates 21 USC §812. Buyer assumes complete Form 222/DEA compliance across jurisdictions; zero medical claims, protocols, or guidance provided.​